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Abstract
Known to cause gas gangrene, Hathewaya histolytica secretes two sister collagenases,
collagenase G (Col G) and collagenase H (Col H), to degrade the triple helical structure
of collagen to further infection in a host. Individual domains of Col H have been
crystalized in previous studies1, 2, 3, but methods in x-ray crystallization of full-length Col
H have been unsuccessful. Using Small Angle X-Ray Scattering (SAXS) data, atomistic
modeling was used to generate multiple conformations of Col H while accounting for
flexibility between domains. Full-length Col H was found to adopt a two-state
conformational model exhibiting a majority compact and a minority elongated form
regardless of calcium concentration. This suggests Col H may become more flexible in
lower calcium concentrations but does not elongate as previously suspected.
Determination of full-length Col H could significantly impact drug delivery design and
therapeutic agents concerning procedures such as skin debridement and pancreatic islet
extraction.4, 5, 6, 7

4

1. Introduction
1.1 Collagenases
Collagen, the most plentiful protein found in animals8, is composed of a triple helical
motif that commonly contains three, parallel polypeptide chains. Tropocollagen utilizes
this triple helical structure to resist degradation by proteases as the scissile peptide bonds
are protected. Because of this, bacteria have evolved to produce collagenases that degrade
collagen fibrils made of tightly packed tropocollagen molecules.
Hathewaya histolytica, a bacterium known to cause gas gangrene, secretes two sister
collagenases, collagenase G and collagenase H to further infection in a host. Col H
consists of four domains: a catalytic module (S1), and a three-part binding segment
consisting of two domains and a collagen binding domain (S2A, S2B, and S3).1 The S2A
and S2B domains resemble polycystic kidney disease-like domains (PKD).9 The fulllength structure of Col H has yet to be determined.
Previous literature suggests a strong correlation between protein flexibility and
structure with calcium concentration.10 Bacterial collagenases require calcium to bind
collagen and reach full catalytic activity.11, 12, 3 As the calcium concentration increases,
Col H adopts a more contoured, rigid, and functional shape. When the calcium
concentration decreases, the protein may become more linear and flexible.2, 10-12 This
elongation at lower calcium concentrations could potentially assist in the secretion of Col
H into the extracellular matrix.
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Figure 1: Domain arrangement of Collagenase H.

1.2 Small Angle X-ray Scattering
The individual domains of Col H have been crystalized in previous studies1,2, 3, but
methods in x-ray crystallization of full-length Col H have been unsuccessful. Small
Angle X-ray Scattering (SAXS), a Low-Resolution Technique, allows an estimation of
the shape of a molecule in solution without crystallization. SAXS has been used to
observe the structure of Col H related to varied calcium concentrations. Preliminary data,
generated using FOXS to compute single state models of Col H in various calcium
concentrations, produced high global fit values that showed no correlation between
theoretical modeling and SAXS experimental curves. Conversely, MultiFoXS utilizes a
population-weighted computation, beginning from a single input structure, by fitting to
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the SAXS scattering curve of the protein. Multi-state modeling, using MultiFoXS, can
result in significantly improved global fit values.13 The combination of SAXS and
atomistic modeling can generate multiple conformations of Col H while accounting for
its flexibility between domains. The method by which Hathewaya histolytica secretes Col
H, as well as Col H’s binding mechanism, processivity along collagen fibers, and
possible synergy with collagenase G, are still unknown. Determination of the full-length
structure of Col H will provide insight into these mechanisms.
1.3 Significant Impacts
Collagenases are currently used in a wide variety of therapeutic agents. For the last 50
years, collagenase H and G have been used in an ointment, SANTYL, that debrides dead
tissue post trauma, allowing fresh skin to grow and accelerating the healing process.6
Injections of Col G and Col H can also be used to treat the excessive growth of
connective tissue found in Dupuytren’s contracture.4 Collagenases break down the extra
collagen and bring temporary relief from the stiffness and constrictions experienced by
affected individuals. Pancreatic islet injections and isolation transplantations employing
the sister collagenases can be used to treat type 1 diabetes.7 The islets are derived from
the patient but are found in deeper tissues which makes extraction difficult without the
use of Col H and Col G. Col H and Col G can also be used to extract pluripotent stem
cells from adipose tissue that can then be used to treat various injuries.5, 14 However, as
of now, cell isolation from collagen rich tissue—for example, from the lung, tendons, or
bone—is not time efficient. Further characterization of Col H could optimize cell
extraction and the degradation of difficult tissues.
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Col H combined with fusion proteins can be used in systematic applications to treat
osteoporosis and to prevent and treat alopecia.15 Tumor treatments can also utilize Col H
to help with drug penetration and to assist in tumor removal; however, after as soon as
the third injection, researchers saw antibodies arise that were capable of neutralizing
collagen.16 Collagenases can also be used in tandem with growth factors; the collagenases
help prevent growth from becoming malignant.17 The noncatalytic segments can also aid
in the attachment of drugs to the site of interest which consequently decreases the drug
dosage needed. Unfortunately, Col H is an immunogenic enzyme leading to inflammation
and reduced effectiveness. Elucidation of the full-length structure of Col H could help
decrease dosage and side effects while increasing efficacy as a therapeutic agent.
2. Materials and Methods
SAXS Sample Preparation of full-length Col H: HBS-EGTA, HBS-Ca, and HBS—three
different HEPES buffered saline (HBS) stock solutions—were prepared consisting of
10mM HEPES, 100mM NaCl, and 0.4mM EGTA. This solution was also made in five
different concentrations of glycerol: 0%, 0.5%, 1%, 1.5%, and 2%. HBS-Ca is comprised
of 10mM HEPES, 100mM NaCl, and 2.4mM CaCl2. HBS consists of 10mM HEPES and
100mM NaCl. The web application MAXCHELATOR was used to mix the five solutions
to a final volume of 100mL with differing calcium concentrations: pCa 3, 4, 5, 6 and
7. Buffer exchange of full-length Col H were performed using Centricon—centrifugal
units with a MWCO of 10 or 30 kDa. For each pCa, each glycerol concentration
was analyzed using Dynamic Light Scattering (DLS) and UV-Vis
Spectrometry. Samples showing no aggregation were selected for data collection at the
SIBYLS beamline.
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SAXS Data Collection: Synchrotron SAXS data from solutions of Full-length Col H in 50
mM Hepes, 100 mM NaCl, 5 mM CaCl2, and pH 7.5 were collected on the 12.3.1
(SIBYLS) beamline at the Advanced Light Source (ALS; Berkeley, CA, USA) using a
Pilatus3 X 2M detector at a wavelength of λ = 0.113 nm (I(s) vs s, where s = 4πsinθ/λ and
2θ is the scattering angle). Five Col H samples were prepared in differing calcium
concentrations as pCa 3-7. Protein concentrations ranging between 1 and 5 mg/ml were
measured at 10°C. 33 successive 0.300 second frames were collected. The data was
normalized to the intensity of the transmitted beam and radially averaged; the scattering
of the solvent-blank was subtracted, and the different curves were scaled for protein
concentration. The low angle data collected at lower concentrations was extrapolated to
infinite dilution and merged with the higher concentration data to yield the final
composite scattering curve.
Scattering for samples with concentrations of 5 mg/ml, 3 mg/ml and 1 mg/ml were
averaged. Each of the average scattering curves were used to extrapolate towards infinite
dilution.
Primary Data Analysis, SCATTER: SAXS data was analyzed using SCATTER and the
ATSAS Suite. Buffer subtracted data for each concentration was subjected to a series of
manual optimizations in SCATTER. Guinier analysis was utilized to remove outlying
residuals; the q*Rc limit range was found at the first plateau of the Rc plot; flexibility and
volume analysis were used together to give a maximum volume estimate of the molecule;
P(r) analysis was used to estimate the Dmax and calculated using GNOM from the
ATSAS suite. Visualization of data was performed using UCSF Chimera V 1.14.
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Multi-State Modelling and MultiFoXS: Refined SAXS profiles were submitted to
MultiFoXS calculations which uses Rapid Random Trees (RRT) to derive and average
multiple conformations of Col H. For MultiFoXS, the flexible residues were identified
using hingeProt. Full-length structure was predicted from the primary sequence using
AlphaFold multimer V 2.018 and subsequently used as the input structure for MultiFoXS
calculations.
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3. Results

Figure 2: Single State Modelling of Full-Length Col H via FoXS. Significant deviation from theoretical (red) and
experimental (black) scattering curve per pCa sample. Deviations suggest samples are not rigid systems.
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Figure 3: Multi-State modelling of Full-length Col H via MultiFoXS. Multi-State Ensembling reduces deviation between
theoretical (red) and experimental scattering (black). Profiles represent the two-state conformational model for each
pCa.
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Figure 4: Highest Population-Weighted Ensemble Models via MultiFoXS.
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Figure 5: Second Highest Population-Weighted Ensemble via MultiFoXS.

Equation 1: Global fit value expression.13
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4. Conclusion
The models constructed using a single state of Col H resulted in high, triple digit
global fit values (figure 2). Significantly high fit values, as seen in FoXS results,
indicates that the one-state models may not approximate experimental scattering results.
The presence of multiple conformations of Col H is evidenced by the reductions in global
fit values of the MultiFoXS data (figure 3) versus the FoXS data (figure 2). The Col H
scattering data coincides better with the multistate modelling, indicating that the protein
may be a flexible system. Interestingly, each pCa concentration exhibited similar
compact structure as the major conformation. These results are counter to the elongation
that was expected to complement flexibility. Differentiating elongation from overall
dynamics is difficult to perform in SAXS alone and may require additional experimental
methods to solve. A trypsin limited proteolysis of Col H, at differing pCa concentrations,
may elucidate the change in dynamics that SAXS results are suggesting.
MultiFoXS results describe a flexible protein—one that may change dynamics in
response to varying calcium concentrations and provides a possible explanation as to the
secretion of the protein. Potentially, lower calcium concentrations of cell cultures during
expression will help facilitate the secretion, and subsequent yield, of Col H. In addition,
higher calcium concentrations may be useful in preserving the integrity of purified
proteins, thus ensuring activity and structure are kept constant over periods of long-term
storage.

15

References
(1) Eckhard, U.; Schönauer, E.; Brandstetter, H. Structural Basis for Activity Regulation
and Substrate Preference of Clostridial Collagenases G, H, and T. Journal of Biological
Chemistry 2013, 288 (28), 20184-20194. DOI: 10.1074/jbc.m112.448548 (acccessed
2021-05-12t15:46:05).
(2) Bauer, R.; Wilson, J. J.; Philominathan, S. T. L.; Davis, D.; Matsushita, O.; Sakon, J.
Structural Comparison of ColH and ColG Collagen-Binding Domains from Clostridium
histolyticum. Journal of Bacteriology 2013, 195 (2), 318-327. DOI: 10.1128/jb.00010-12
(acccessed 2021-05-12t15:37:09).
(3) Wilson, J. J. A bacterial collagen-binding domain with novel calcium-binding motif
controls domain orientation. The EMBO Journal 2003, 22 (8), 1743-1752. DOI:
10.1093/emboj/cdg172 (acccessed 2021-05-14t02:11:33).
(4) Gaston, R. G.; Larsen, S. E.; Pess, G. M.; Coleman, S.; Dean, B.; Cohen, B. M.;
Kaufman, G. J.; Tursi, J. P.; Hurst, L. C. The Efficacy and Safety of Concurrent Collagenase
Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A
Prospective, Multicenter Study. J Hand Surg Am 2015, 40 (10), 1963-1971. DOI:
10.1016/j.jhsa.2015.06.099.
(5) Carson, C. r. Analysis of the clinical safety of intralesinal injection of collagenase
Clostridiumhistolyticum (CCH) for adults with Peyronie’s disease (PD). Sadeghi-Nejad, H.,
Ed.; BJU Int.: BJU Int., 2015.
(6) Shi, L.; Carson, D. Collagenase Santyl ointment: a selective agent for wound
debridement. J Wound Ostomy Continence Nurs 2009, 36 (6 Suppl), S12-16. DOI:
10.1097/WON.0b013e3181bfdd1a.
(7) Li, D.; Peng, S.-Y.; Zhang, Z.-W.; Feng, R.-C.; Li, L.; Liang, J.; Tai, S.; Teng, C.-B.
Complete disassociation of adult pancreas into viable single cells through cold trypsinEDTA digestion. Journal of Zhejiang University SCIENCE B 2013, 14 (7), 596-603. DOI:
10.1631/jzus.b1200226 (acccessed 2021-05-12t15:58:26).
(8) Shoulders, M. D.; Raines, R. T. Collagen Structure and Stability. Annual Review of
Biochemistry 2009, 78 (1), 929-958. DOI: 10.1146/annurev.biochem.77.032207.120833
(acccessed 2021-05-14t02:10:32).
(9) Bauer, R.; Janowska, K.; Taylor, K.; Jordan, B.; Gann, S.; Janowski, T.; Latimer, E. C.;
Matsushita, O.; Sakon, J. Structures of three polycystic kidney disease-like domains
fromClostridium histolyticumcollagenases ColG and ColH. Acta Crystallographica Section
D Biological Crystallography 2015, 71 (3), 565-577. DOI: 10.1107/s1399004714027722
(acccessed 2021-05-12t15:38:13).
16

(10) Ohbayashi, N.; Matsumoto, T.; Shima, H.; Goto, M.; Watanabe, K.; Yamano, A.;
Katoh, Y.; Igarashi, K.; Yamagata, Y.; Murayama, K. Solution structure of clostridial
collagenase H and its calcium-dependent global conformation change. Biophys J 2013,
104 (7), 1538-1545. DOI: 10.1016/j.bpj.2013.02.022.
(11) Caviness, P.; Bauer, R.; Tanaka, K.; Janowska, K.; Roeser, J. R.; Harter, D.; Sanders, J.;
Ruth, C.; Matsushita, O.; Sakon, J. Ca 2+ -induced orientation of tandem collagen binding
domains from clostridial collagenase ColG permits two opposing functions of collagen
fibril formation and retardation. The FEBS Journal 2018, 285 (17), 3254-3269. DOI:
10.1111/febs.14611 (acccessed 2021-05-12t15:43:48).
(12) Philominathan, S. T. L.; Matsushita, O.; Jordan, J. B.; Sakon, J. H-1, C-13 and N-15
resonance assignments of Ca2+ bound collagen-binding domain derived from a
clostridial collagenase. Biomolecular Nmr Assignments 2008, 2 (2), 127-129. DOI:
10.1007/s12104-008-9102-z.
(13) Schneidman-Duhovny, D.; Hammel, M.; Tainer, J. A.; Sali, A. FoXS, FoXSDock and
MultiFoXS: Single-state and multi-state structural modeling of proteins and their
complexes based on SAXS profiles. Nucleic Acids Research 2016, 44 (W1), W424-W429.
DOI: 10.1093/nar/gkw389 (acccessed 2020-11-13t18:16:53).
(14) Riley, K. N.; Herman, I. M. Collagenase promotes the cellular responses to injury and
wound healing in vivo. J Burns Wounds 2005, 4, e8.
(15) Katikaneni, R.; Ponnapakkam, T.; Suda, H.; Miyata, S.; Sakon, J.; Matsushita, O.;
Gensure, R. C. Treatment for chemotherapy-induced alopecia in mice using parathyroid
hormone agonists and antagonists linked to a collagen binding domain. Int J Cancer
2012, 131 (5), E813-821. DOI: 10.1002/ijc.27379. Katikaneni, R.; Ponnapakkam, T.;
Matsushita, O.; Sakon, J.; Gensure, R. Treatment and prevention of chemotherapyinduced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a
non-depilated mouse model. Anti-Cancer Drugs 2014, 25 (1), 30-38. DOI:
10.1097/CAD.0b013e3283650bff. Katikaneni, R.; Seymour, A. W.; Gulati, R.;
Ponnapakkam, T.; Gensure, R. C. Therapy for Alopecia Areata in Mice by Stimulating the
Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain. J
Investig Dermatol Symp Proc 2015, 17 (2), 13-15. DOI: 10.1038/jidsymp.2015.32.
(16) Dolor, A.; Szoka, F. C. Digesting a Path Forward: The Utility of Collagenase Tumor
Treatment for Improved Drug Delivery. Molecular Pharmaceutics 2018, 15 (6), 20692083. DOI: 10.1021/acs.molpharmaceut.8b00319 (acccessed 2021-05-12t16:36:12).
(17) Ponnapakkam, T.; Katikaneni, R.; Sakon, J.; Stratford, R.; Gensure, R. C. Treating
osteoporosis by targeting parathyroid hormone to bone. Drug Discovery Today 2014, 19
(3), 204-208. DOI: 10.1016/j.drudis.2013.07.015.

17

(18) Jumper, J.; Evans, R.; Pritzel, A.; Green, T.; Figurnov, M.; Ronneberger, O.;
Tunyasuvunakool, K.; Bates, R.; Žídek, A.; Potapenko, A.; et al. Highly accurate protein
structure prediction with AlphaFold. Nature 2021, 596 (7873), 583-589. DOI:
10.1038/s41586-021-03819-2. Varadi, M.; Anyango, S.; Deshpande, M.; Nair, S.;
Natassia, C.; Yordanova, G.; Yuan, D.; Stroe, O.; Wood, G.; Laydon, A.; et al. AlphaFold
Protein Structure Database: massively expanding the structural coverage of proteinsequence space with high-accuracy models. Nucleic Acids Res 2022, 50 (D1), D439-D444.
DOI: 10.1093/nar/gkab1061.

18

